Seeing Is Believing
Currently out of the existing stock ratings of Matthew Caufield, 65 are a BUY (91.55%), 6 are a HOLD (8.45%).
Analyst Matthew Caufield, carries an average stock price target met ratio of 25.6% that have a potential upside of 15.89% achieved within 38 days. Previously, Matthew Caufield worked at HC WAINWRIGHT.
Matthew Caufield’s has documented 137 price targets and ratings displayed on 14 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on OPT, Opthea Ltd at 28-Feb-2025.
Analyst best performing recommendations are on EYEN (EYENOVIA).
The best stock recommendation documented was for EYEN (EYENOVIA) at 11/13/2024. The price target of $12 was fulfilled within 2 days with a profit of $20.6 (63.19%) receiving and performance score of 315.95.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10
$4.89 (95.69%)
$10
6 months 22 days ago
(09-Aug-2024)
0/9 (0%)
$4.9 (96.08%)
Buy
$10
$4.89 (95.69%)
6 months 23 days ago
(08-Aug-2024)
0/1 (0%)
$5.81 (138.66%)
Buy
$8
$2.89 (56.56%)
$25
1 years 4 months 14 days ago
(17-Oct-2023)
0/10 (0%)
$6.16 (334.78%)
Hold
$14
1 years 4 months 14 days ago
(17-Oct-2023)
2/3 (66.67%)
$6.42 (84.70%)
362
Buy
3 years 2 months 5 days ago
(27-Dec-2021)
0/1 (0%)
$9.48 (75.72%)
Which stock is Matthew Caufield is most bullish on?
Which stock is Matthew Caufield is most reserved on?
What Year was the first public recommendation made by Matthew Caufield?